Immunitas Therapeutics
Matthew Huggins is a Senior Scientist at Immunitas Therapeutics since November 2021, with previous experience as a Postdoctoral Fellow at the University of Minnesota-Twin Cities, a Graduate Student at Mayo Clinic, a Research Technician at Albert Einstein College of Medicine, and a Research Assistant at the University of Wisconsin. Matthew's research focuses on memory T cell biology and improving T cell-based vaccines. Matthew holds a PhD in Immunology from Mayo Clinic Graduate School of Biomedical Sciences and a Bachelor of Science in Biochemistry and History from the University of Wisconsin-Madison.
Immunitas Therapeutics
Immunitas is an immuno-oncology therapeutics company advancing multiple programs to the clinic. Immunitas’ programs are derived from a cross-functional, highly integrated, single-cell genomics platform that enables rapid target identification and validation in parallel with antibody discovery and engineering.